KEY PRODUCTS
Maithri Drugs: Dedicated to your API needs.
01 1Maithri Drugs
01 1SODIUM SULFATE ANHYDROUS USP
01 1India
01 1Active
01 1Complete
Maithri Drugs: Dedicated to your API needs.
GDUFA
DMF Review : Complete
Rev. Date : 2025-11-28
Pay. Date : 2025-09-29
DMF Number : 40138
Submission : 2024-06-27
Status : Active
Type : II
20
Maithri Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Maithri Drugs: Dedicated to your API needs.
One of their notable products is SODIUM SULFATE ANHYDROUS USP, with a corresponding US DMF Number 40138.
Remarkably, this DMF maintains an Active status since its submission on June 27, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 28, 2025, and payment made on September 29, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
